Description
Molecular Analysis for Therapy Choice (MATCH)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma
This trial is available at multiple Sutter Locations. Please contact one of the following about Study Match EAY 131
San Francisco: ClinicalResearch@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
East Bay: James Nasman NasmanJ@sutterhealth.org and Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: Isabel Rodrigues-Fong Rodrigi@sutterhealth.org and Kirsten Babski babskik@sutterhealth.org
Modesto: Delia Massone MassonD@sutterhealth.org and Adrienne Palos PalosA@sutterhealth.org
Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals@sutterhealth.org
View study details on ClinicalTrials.gov
Principal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2017
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: David Yee, M.D., MPH, Brian K. Kim, M.D, Kristie A. Bobolis, M.D., Vijay Suhag, M.D., Rajeswari Chellappah, M.D., Sivakumar Reddy, M.D., Kristin N. Arreola, M.D., Nitin Rohatgi, MD